THE MARKETING GROUP PLC ACQUIRES ULYSSES LTD, EXTENDING

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
THE MARKETING GROUP PLC ACQUIRES ULYSSES LTD, EXTENDING GLOBAL REACH INTO U.S MARKET

· Acquisition of Ulysses Ltd marks a watershed moment for The Marketing Group Plc as it establishes position in the U.S with subsidiary marketing businesses Wilkin Marketing and Skye. · With the acquisition of Ulysses Ltd, The Marketing Group Plc also acquires its subsidiaries Marker Metro, an application and game development studio based in New Zealand, and Clickverta, an inbound marketing consultancy bring new skills to the group. · Earnings per share will increase from 12.9 cents to 19.5 cents post acquisition. · EBITDA will increase by approximately 2.08m Euros in exchange for a share capital increase of approximately 4.5m shares (at a strike of 4.15 per share, with a total value of 18,582,781 Euros). · A 10-day volume weighted average was used to determine the strike price of the purchase shares, giving a share price of 4.15 Euros per share. · EBITDA of the group will increase by approximately 89% in exchange for a share capital increase of approximately 25%. Stockholm, July 25th 2016 - The Marketing Group plc, a 360 digital company, today announces the strategic acquisition of Ulysses Ltd and its subsidiary businesses Wilkin Marketing (promotional marketing) and Skye (multimedia training solutions) in a move that establishes the group’s U.S presence and extends its geographical footprint to new markets. Along with the U.S based marketing businesses, Ulysses Ltd consists of two other subsidiary businesses – Marker Metro, which brings unparalleled technology skills and a stake in the massive mobile app and branded gaming space, and Clickverta, an inbound marketing agency with a strong Nordic presence. The deal to acquire Ulysses Ltd and its subsidiaries was agreed at a strike price of 4.15 Euros per share, with a total value of 18,582,791 Euros. Following this acquisition, the total number of ordinary shares issued by The Marketing Group will increase from 18,212,787 to 22,690,566. This requires the creation of 4,477,779 new ordinary shares, over 50% of which will be subject to a 360-day lockup period. A 10-day volume weighted average was used to determine the strike price of the purchase shares, giving a share price of 4.15 Euros per share. The acquisition will increase the EBITDA of the group by approximately 89% in exchange for a share capital increase of approximately 25%. Jeremy Harbour, Executive Chairman of The Marketing Group comments, “I am delighted to welcome the new members to the group. It represents a major step forward in both size and geography, and also to have been able to complete our second major acquisition before our two month mark is testament to the value of the model. I am now very confident that many more companies will soon join our ranks and cement our position as an important global player in the marketing services space.” The acquisition is part of The Marketing Group’s strategic portfolio approach – the agglomeration model - designed to offer clients a true, global marketing service with a full spectrum of specialist services and world-class talent.  It marks a further step towards The Marketing Group’s declared goal of developing its networks in fast growth markets and across key sectors. Financials +-------------------------------------------+----------+ |EBITDA (The Marketing Group) for Year 2016*|2,349,875 | +-------------------------------------------+----------+ |EBITDA (Ulysses) for Year 2016* |2,087,953 | +-------------------------------------------+----------+ |Post-acquisition EBITDA (pro forma) |4,437,828 | +-------------------------------------------+----------+ |Earnings Per Share (Current) |12.9 cents| +-------------------------------------------+----------+ |Earnings Per Share (Post-acquisition) |19.5 cents| +-------------------------------------------+----------+ *Based on forecast pro forma of all companies as if they were all contributing to the periods listed ULYSESS Group Headline Financials adjusted to Euros* 2015                                                          2016E +-----------------+---------------+-------------+---------------+-------------+ |Company |Turnover(Euros)|EBITDA(Euros)|Turnover(Euros)|EBITDA(Euros)| +-----------------+---------------+-------------+---------------+-------------+ |Wilkin Marketing*|3,354,810 |222,591 |4,008,840 |580,357 | +-----------------+---------------+-------------+---------------+-------------+ |Skye |1,074,252 |142,168 |1,221,467 |295,562 | +-----------------+---------------+-------------+---------------+-------------+ |Clickverta |536,958 |157,594 |636,958 |207,594 | +-----------------+---------------+-------------+---------------+-------------+ |Marker Metro |2,662,790 |830,747 |2,431,069 |1,004,441 | +-----------------+---------------+-------------+---------------+-------------+ |TOTAL |7,628,810 |1,353,100 |8,298,335 |2,087,953 | +-----------------+---------------+-------------+---------------+-------------+ *Pending tax and valuation consideration ULYSSES LTD GROUP COMPANIES MARKER METRO LTD Founded by Keith Patton (CEO and Microsoft Regional Director) and Jon Beattie (Director) in 2011, Marker Metro Ltd creates chart-topping games and world-class apps for top publishers and brands. Renowned for deep application technical skills, creative flair and an unflinching attention to detail, Marker Metro is trusted in the delivery of high profile cross platform applications across Windows, iOS, Google Play and Amazon platforms. Marker Metro is also one of the world’s leading game porting and co-development studios delivering major games for top US publishers across any mobile or TV based gaming platform. Headquartered in Auckland, New Zealand, Marker Metro has major clients across New Zealand, Australia, US and the UK serviced by a dedicated team of producers, developers, artists, designers and quality assurance staff. Key Client experience includes Disney Mobile, Commonwealth Bank and Air New Zealand. WILKIN MARKETING Founded by Rusty Donohoo, Wilkin Marketing is a full service marketing firm, specialising in direct mail and promotional marketing with a focus on the Gaming, Retail, Travel, & Hospitality industries. Wilkin Marketing offers a complete array of marketing products and services - from full-service agency services to in-house variable data print direct mail production. Wilkin Marketing has developed fully integrated kiosks solutions that are self-coping with a loyalty interface that allow guests to spend more time enjoying the business rewards and less time waiting in lines. Along with its partner Mail America, they have developed thousands of promotions; sent millions of targeted communication via direct mail, email, and SMS text; and installed hundreds of kiosks throughout the United States and Canada. Wilkin Marketing can assist in database marketing activities – from segmentation to re-investment optimization. It can also assist with e-marketing efforts – from PURL’s to website creation to targeted email marketing, SMS/text marketing and social media marketing. Each Kiosk is custom designed to meet clients’ needs. Key client experience includes American Sales Industries, Canadian Upsell, Rebs Mail and Fuccillo Kia of Cape Coral. SKYE MULTIMEDIA Founded by Seth Oberman, CEO and Owner in 1995, Skye MM, LLC (Skye) delivers training solutions with a specific focus on the Healthcare industry. The team consists of instructional designers, writers, graphic designers, animators, developers, and project managers who provide end-to-end delivery of business solutions. Skye was formed in April of 1995 and has developed hundreds of training applications for many of today’s Fortune 1000 companies. From 2006 to 2014 Skye was a wholly owned subsidiary of SmartPros Ltd. (NASDAQ: SPRO). SmartPros was recently acquired by Kaplan, Inc., the global education services company and largest subsidiary of Graham Holdings (NYSE:GHC). In January 2015 Skye once again became privately owned forming officially as Skye MM, LLC. Key client experience includes Deloitte, Morgan Stanley, Novartis, KPMG and Pfizer. CLICKVERTA Founded by James Downton and based in Lithuania, Clickverta is an International Performance Marketing Consultancy that engineers predictable sales revenue for premium service B2B businesses and B2B SaaS companies. Fast growth B2B companies rely on a fresh supply of highly qualified leads into their business, and through our the Clickverta Methodology™, they help businesses better understand their audience, and better communicate the value of their services. Key client experience includes LNK, JSC, Rabota dlia vas, ODO and Nestle Baltics. For more information, please contact Hannah Middleton, Director and Communications Director Phone: +65 8193 7625 E-mail: hannah.middleton@marketinggroupplc.com Jeremy Harbour, Executive Chairman Phone: +65 8661 1776 E-mail: jeremy.harbour@marketinggroupplc.com The Marketing Group in brief The Marketing Group plc was incorporated in May 2015 with the purpose of gathering successful marketing businesses under one roof. During the first half of 2016, The Marketing Group acquired 9 companies with specialist skills and geographical reach. The Company comprises a series of independent marketing teams, each with specific expertise and innovative services. The consolidated group supports the subsidiaries with management and coordinating activities as well as a common operating platform. For more information, please visit the Company’s website www.marketinggroupplc.com. The Company’s share is listed on Nasdaq First North Stockholm from 8 June 2016 and Mangold Fondkommission AB, +46 8-5030 15 50, is the Company’s Certified Adviser and liquidity provider. FOOTNOTE: Jeremy Harbour and Callum Laing abstained from voting on the acquisition due to a commercial conflict of interests; James Downton and Charles Bartholomew abstained from voting due to a management conflict of interests, the vote to acquire Ulysses was carried by the remainder of the board unanimously. There are no materially declarable new clients, shareholders or suppliers as a result of the transaction.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

BASIS Bellevue Expands with New K-4 Campus

Updated Category News Views 89

A New Era for Young Learners in Bellevue When a community-driven school like BASIS Independent Bellevue makes a move to expand, it doesn't happen in a vacuum. They're not just building another campus—they're aiming to sculpt the future right here in Bellevue, and boy, do they have a plan. The new Lower School campus opening come Fall 2027 is dedicated to kiddos in...

Continue Reading
Smirnoff Launches Marvel Event with $12.99 Offer

Updated Category News Views 68

Smirnoff's Bold Move to Ride Marvel's Coattails Here we are, watching a vodka brand hitch its wagon to a Hollywood juggernaut. Smirnoff has announced a fan experience to toast Marvel Studios' "Avengers: Doomsday." Of course, this isn't just about clinking glasses; it's a marketing stunt dressed in superhero tights. The impressive part? They’re selling the razzmatazz for...

Continue Reading
Ameritas Hires Actuarial Veteran as VP in Strategic Move

Updated Category News Views 115

Shifting Gears at Ameritas: New VP Takes the Helm Well, chalk one up for Ameritas on this move. They've just brought on Ying Zhao as the new vice president of actuarial and financial strategy. It's a mouthful of a title, sure, but it's the role itself that's worth watching. Ameritas, for those not tracking, is a major player in the insurance and financial universe, doing...

Continue Reading
Amgen Q3 2026 Results: What Investors Should Know

Updated Category News Views 93

Amgen Prepares to Reveal Third Quarter 2026 Financials If there's one thing I've learned about investing, it's that the devil's in the details, and Amgen's (NASDAQ:AMGN) upcoming webcast for its third quarter 2026 financial results is exactly the kind of detail that sets market-watchers' hearts racing. Scheduled for November 3, just after the U.S. markets close, this is...

Continue Reading
Royce Global Trust: Insights on RGT's Performance

Updated Category News Views 80

Analyzing Royce Global Trust's Approach When you dig into the Royce Global Trust portfolio, what emerges is a tapestry woven through decades of grit and determination in the investing world. This closed-end fund, trading under the symbol NYSE: RGT, is no stranger to the ebbs and flows of global markets. With every tick of the clock, speculation dances around this fund's...

Continue Reading
transcosmos: Not Just Calls—Evolving Business Strategy

Updated Category News Views 110

Turning Talk into Triumphs Award chatter isn't exactly rare in this industry, but the latest accolades rolling in for transcosmos from the Best Contact Center Indonesia 2026 ain't your run-of-the-mill pat on the back. Sure, a trophy's a trophy, but when they snatch Gold in the Business Contribution category and another shiny Silver in People Development, it’s hinting at...

Continue Reading
Bloomberg Law Awards Series Celebrates Legal Excellence

Updated Category News Views 54

New Awards Shine Light on Corporate Legal Teams Here's one for the books: Bloomberg Law is rolling out a shiny new awards program called Inside In-House: Legal Departments of the Year. Now, this isn't some vanity affair because it's aimed at celebrating the folks in legal teams who make companies tick behind the scenes. Openings for nominations run through November 20,...

Continue Reading
Oracle's Bold Vision: Targeting $225B Revenue by 2030

Updated Category News Views 132

Oracle Lays Down a Bold Gauntlet Oracle Corporation (NYSE: ORCL) sure knows how to draw the spotlight. With their recent Investor Day in Vegas, they've laid out ambitions that could make even the most seasoned Wall Streeter spit out their coffee. Who would've thought they'd be betting on a whopping $225 billion in revenue by FY30? That's supposed to be a more than 35%...

Continue Reading
BD's New Liverty™ TIPS Stent: A Game Changer?

Updated Category News Views 75

Could This Be the Breakthrough for Portal Hypertension? Now, here's something that might just turn a few heads in the medical world. BD has launched their Liverty™ TIPS Stent Graft in the U.S., a move set to shake up the landscape for treating portal hypertension. This isn't just another shiny new gadget—it's a promise of more personalized patient care in a field...

Continue Reading
Ascletis' ASC30 Achieves Significant HbA1c Reductions

Updated Category News Views 73

When you dive into the world of biopharma, you never quite know what's going to grab your attention next. Today, it's Ascletis Pharma's (HKEX: 1672) GLP-1 receptor agonist, ASC30, that's piqued my interest. It just wrapped up a U.S. Phase II study with a bang, showing off with some impressive results for type 2 diabetes treatment. This ain't no half-hearted...

Continue Reading

Top 5 Most Recently Viewed Articles

Innovative AI Assistant by ClickBid Revolutionizes Fundraising

Updated Category News Views 155

ClickBid Introduces Groundbreaking AI Assistant ClickBid, recognized as a pioneer in event fundraising technology, proudly presents ClickBid Search. This is the first custom GPT-powered AI assistant tailored specifically for nonprofits, designed to offer immediate and relevant answers to help organizations optimize their event strategies. Available at no cost to all...

Continue Reading
TIER IV and TUM Drive Level 4 Autonomous Cars

Updated Category News Views 25

Autonomous Driving Gets a German Boost Well folks, looks like the autonomous vehicle scene is hitting the autobahns with more horsepower than ever before. Today’s chatter is all about how TIER IV and the Technical University of Munich (TUM) have teamed up, tapping into the grid as they ride the waves of cutting-edge NVIDIA tech. The Sparks Under the Hood: NVIDIA...

Continue Reading
Vericel Corporation's Upcoming Presentation at MedTech Conference

Updated Category News Views 147

Vericel Corporation's Engagement at the MedTech Conference CAMBRIDGE, Mass. — Vericel Corporation (NASDAQ:VCEL), a recognized leader in advanced therapies for sports medicine and severe burn care, has exciting news regarding its participation at the upcoming Truist Securities MedTech Conference. The company will be featured in a fireside chat, slated to take place at...

Continue Reading
Gildan Achieves Strong Q2 Results: Revenue and Finances Surge

Updated Category News Views 128

Gildan Reports Remarkable Growth in Second Quarter Earnings Gildan Activewear Inc. (NYSE: GIL, TSX: GIL) has achieved record net sales of $919 million during the second quarter, reflecting a strong 6.5% increase compared to the previous year. Strong Operational Performance and Profitability This quarter's operating margin stood at an impressive 21.7%, with an adjusted...

Continue Reading
MimiVax and UI Pharmaceuticals Mark Key Production Milestone

Updated Category News Views 260

MimiVax and UI Pharmaceuticals Mark Key Production Milestone MimiVax and UI Pharmaceuticals have achieved an exciting development in the field of cancer treatment with the clinical manufacture of SurVaxM, an innovative immunotherapeutic vaccine aimed at targeting glioblastoma. SurVaxM proudly stands out as the first product to be manufactured at UI Pharmaceuticals' newly...

Continue Reading